Login / Signup

A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects.

Damien P KennyAndreas EickenIngo DähnertYounes BoudjemlineHorst SievertMartin Be SchneiderTommaso GoriZiyad M Hijazinull null
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
The OFFII device was not inferior to the ASO with less complications and greater efficacy than the ASO.
Keyphrases
  • hypertrophic cardiomyopathy
  • atrial fibrillation
  • study protocol
  • left atrial appendage
  • phase iii
  • clinical trial
  • phase ii
  • risk factors
  • left atrial
  • left ventricular
  • mitral valve